{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T08:58:47Z","timestamp":1753520327677},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T00:00:00Z","timestamp":1341014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4de"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s00132-012-1926-7","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T09:24:04Z","timestamp":1340875444000},"page":"533-538","source":"Crossref","is-referenced-by-count":5,"title":["Diagnose und Therapie der axialen Spondyloarthritis einschlie\u00dflich des Morbus Bechterew"],"prefix":"10.1007","volume":"41","author":[{"given":"D.","family":"Poddubnyy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,6,30]]},"reference":[{"key":"1926_CR1","doi-asserted-by":"crossref","unstructured":"Baraliakos X, Berg R van den, Braun J, Heijde D van der (2012) Update of the literature review on treatment with biologics as a basis for the first update of the ASAS\/EULAR management recommendations of ankylosing spondylitis. Rheumatology (Oxford). [Epub ahead of print]","DOI":"10.1093\/rheumatology\/kes026"},{"key":"1926_CR2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22669","volume":"57","author":"Braun","year":"2007","unstructured":"Braun J, Baraliakos X, Listing J et al (2007) Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 57:639\u2013647","journal-title":"Arthritis Rheum"},{"key":"1926_CR3","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1002\/art.21197","volume":"52","author":"Braun","year":"2005","unstructured":"Braun J, Baraliakos X, Listing J, Sieper J (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52:2447\u20132451","journal-title":"Arthritis Rheum"},{"key":"1926_CR4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","volume":"41","author":"Braun","year":"1998","unstructured":"Braun J, Bollow M, Remlinger G et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58\u201367","journal-title":"Arthritis Rheum"},{"key":"1926_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"Braun","year":"2007","unstructured":"Braun J, Sieper J (2007) Ankylosing spondylitis. Lancet 369:1379\u20131390","journal-title":"Lancet"},{"key":"1926_CR6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"Braun","year":"2011","unstructured":"Braun J, Berg R van den, Baraliakos X et al (2011) 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70:896\u2013904","journal-title":"Ann Rheum Dis"},{"key":"1926_CR7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/ard.2009.121533","volume":"69","author":"Dougados","year":"2010","unstructured":"Dougados M, Combe B, Braun J et al (2010) A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial. Ann Rheum Dis 69:1430\u20131435","journal-title":"Ann Rheum Dis"},{"key":"1926_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-002-0237-4","volume":"23","author":"Feldtkeller","year":"2003","unstructured":"Feldtkeller E, Khan MA, Heijde D van der et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23:61\u201366","journal-title":"Rheumatol Int"},{"key":"1926_CR9","first-page":"2286","volume":"21","author":"Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"1926_CR10","first-page":"20","volume":"Suppl","author":"Haibel","year":"2006","unstructured":"Haibel H, Rudwaleit M, Heldmann F et al (2006) Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis: results of a 12-week, randomized controlled trial. ACR Suppl (504) L24:20\u201321","journal-title":"ACR"},{"key":"1926_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","volume":"7","author":"Khan","year":"1995","unstructured":"Khan MA (1995) HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 7:263\u2013269","journal-title":"Curr Opin Rheumatol"},{"key":"1926_CR12","doi-asserted-by":"crossref","unstructured":"Kroon F, Landewe R, Dougados M, Heijde D van der (2012) Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis. [Epub ahead of print]","DOI":"10.1136\/annrheumdis-2012-201370"},{"key":"1926_CR13","doi-asserted-by":"crossref","unstructured":"Poddubnyy D, Rudwaleit M, Haibel H et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. [Epub ahead of print]","DOI":"10.1136\/annrheumdis-2011-201252"},{"key":"1926_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3899\/jrheum.081048","volume":"36","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Claudepierre P, Wordsworth P et al (2009) Effectiveness, safety, and predictors of good clinical response in 1250 patients treated with adalimumab for active ankylosing spondylitis. J Rheumatol 36:801\u2013808","journal-title":"J Rheumatol"},{"key":"1926_CR15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/ard.2005.051045","volume":"65","author":"Rudwaleit","year":"2006","unstructured":"Rudwaleit M, Feldtkeller E, Sieper J (2006) Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis 65:1251\u20131252","journal-title":"Ann Rheum Dis"},{"key":"1926_CR16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/art.24483","volume":"60","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Haibel H, Baraliakos X et al (2009) The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort. Arthritis Rheum 60:717\u2013727","journal-title":"Arthritis Rheum"},{"key":"1926_CR17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/ard.2009.110767","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Jurik AG, Hermann KG et al (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS\/OMERACT MRI group. Ann Rheum Dis 68:1520\u20131527","journal-title":"Ann Rheum Dis"},{"key":"1926_CR18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Landewe R, Heijde D van der et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770\u2013776","journal-title":"Ann Rheum Dis"},{"key":"1926_CR19","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1136\/ard.2007.073098","volume":"67","author":"Rudwaleit","year":"2008","unstructured":"Rudwaleit M, Schwarzlose S, Hilgert ES et al (2008) MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 67:1276\u20131281","journal-title":"Ann Rheum Dis"},{"key":"1926_CR20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","volume":"63","author":"Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Heijde D van der, Khan MA et al (2004) How to diagnose axial spondyloarthritis early. Ann Rheum Dis 63:535\u2013543","journal-title":"Ann Rheum Dis"},{"key":"1926_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","volume":"68","author":"Rudwaleit","year":"2009","unstructured":"Rudwaleit M, Heijde D van der, Landewe R et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777\u2013783","journal-title":"Ann Rheum Dis"},{"key":"1926_CR22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/ard.2007.075309","volume":"67","author":"Sieper","year":"2008","unstructured":"Sieper J, Klopsch T, Richter M et al (2008) Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis 67:323\u2013329","journal-title":"Ann Rheum Dis"},{"key":"1926_CR23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/ard.2004.028753","volume":"64","author":"Sieper","year":"2005","unstructured":"Sieper J, Rudwaleit M (2005) Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care. Ann Rheum Dis 64:659\u2013663","journal-title":"Ann Rheum Dis"},{"key":"1926_CR24","first-page":"970","volume":"63","author":"Sieper","year":"2011","unstructured":"Sieper J, Heijde D van der, Dougados M et al (2011) Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis \u2013 results from a phase 3 study. Arthritis Rheum 63(Suppl):970","journal-title":"Arthritis Rheum"},{"key":"1926_CR25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/ard.2010.139667","volume":"70","author":"Song","year":"2011","unstructured":"Song IH, Hermann K, Haibel H et al (2011) Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 70:590\u2013596","journal-title":"Ann Rheum Dis"},{"key":"1926_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/art.23275","volume":"58","author":"Song","year":"2008","unstructured":"Song IH, Poddubnyy DA, Rudwaleit M, Sieper J (2008) Benefits and risks of ankylosing spondylitis treatment with nonsteroidal antiinflammatory drugs. Arthritis Rheum 58:929\u2013938","journal-title":"Arthritis Rheum"},{"key":"1926_CR27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/rheumatology\/34.11.1074","volume":"34","author":"Underwood","year":"1995","unstructured":"Underwood MR, Dawes P (1995) Inflammatory back pain in primary care. Br J Rheumatol 34:1074\u20131077","journal-title":"Br J Rheumatol"},{"key":"1926_CR28","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.20985","volume":"52","author":"Heijde","year":"2005","unstructured":"Heijde D van der, Baraf HS, Ramos-Remus C et al (2005) Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study. Arthritis Rheum 52:1205\u20131215","journal-title":"Arthritis Rheum"},{"key":"1926_CR29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/ard.2010.147744","volume":"70","author":"Vastesaeger","year":"2011","unstructured":"Vastesaeger N, Heijde D van der, Inman RD et al (2011) Predicting the outcome of ankylosing spondylitis therapy. Ann Rheum Dis 70:973\u2013981","journal-title":"Ann Rheum Dis"},{"key":"1926_CR30","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","volume":"52","author":"Wanders","year":"2005","unstructured":"Wanders A, Heijde D, Landewe R et al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 52:1756\u20131765","journal-title":"Arthritis Rheum"}],"container-title":["Der Orthop\u00e4de"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-012-1926-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00132-012-1926-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-012-1926-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T06:45:52Z","timestamp":1561877152000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00132-012-1926-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,30]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s00132-012-1926-7","relation":{},"ISSN":["0085-4530","1433-0431"],"issn-type":[{"value":"0085-4530","type":"print"},{"value":"1433-0431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,30]]}}}